-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Eli Lilly, Lowers Price Target to $1050

Benzinga·05/02/2025 22:23:49
Listen to the news
UBS analyst Trung Huynh maintains Eli Lilly (NYSE:LLY) with a Buy and lowers the price target from $1100 to $1050.